Add Yahoo as a preferred source to see more of our stories on Google. Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and ...

In 2017, the FDA approved semaglutide, an injectable GLP-1 agonist medication sold under the name Ozempic, for the management of type 2 diabetes. Later, the pharmaceutical company that makes Ozempic ...

Over the past few weeks, the FDA has devoted lots of attention to compounding pharmacies, issuing two new guidance documents pertaining to their fundamental scope, a guidance document regarding ...

When you have to go on a medication, your doctor will probably prescribe a premade one that's FDA-approved. But sometimes, they may want you to go on a compounded medicine that's specifically made for ...

Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and possible side effects in compounded meds. Lifestyle habits—like diet, ...

Pharmacy compounding is one of the topics in the EU Pharma Law Package that has perhaps received less attention compared to topics such as regulatory exclusivity rights, shortages, and sustainability.